Industry-independent early-stage venture capital fund focusing on innovative B2B technologies, life sciences start-ups and spin-offs in Austria
| Company Name | Tecnet Equity |
| Investment Thesis/Focus | Industry-independent early-stage venture capital fund focusing on innovative B2B technologies, life sciences start-ups and spin-offs in Austria |
| Headquarters Location | Vienna, Austria |
| Founding Year | approximately 2005 (20+ years of experience mentioned on website as of 2026) |
| Investment Stage/Check Size | Early-stage; initial investments of approximately €300,000 |
| Founding/Managing Partners | Dr. Doris Agneter (Geschäftsführerin/Managing Director) |
| Number of Public Team Members | 5 (Dr. Doris Agneter - Managing Director; Dr. Christian Laurer - Senior Investment Manager; Mag. René Danzinger - Investment Manager; Mag. Jürgen Milde-Ennöckl - Investment Manager; Peter Buchinger, BSC - Analyst) |
| Legal Entity | NÖ Technologiebeteiligungs-Invest GmbH |
| Public Contact Email (firm domain) | agneter@tecnet.at (Managing Director) |